JFNIX
Price
$70.64
Change
+$0.56 (+0.80%)
Updated
Sep 5 closing price
Net Assets
4.28B
LHCFX
Price
$20.28
Change
+$0.26 (+1.30%)
Updated
Sep 8 closing price
Net Assets
7.8M
Interact to see
Advertisement

JFNIX vs LHCFX

Header iconJFNIX vs LHCFX Comparison
Open Charts JFNIX vs LHCFXBanner chart's image
Janus Henderson Global Life Sciences I
Price$70.64
Change+$0.56 (+0.80%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care F
Price$20.28
Change+$0.26 (+1.30%)
VolumeN/A
Net Assets7.8M
JFNIX vs LHCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCFX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. LHCFX (7.8M). LHCFX pays higher dividends than JFNIX: LHCFX (0.45) vs JFNIX (0.39). JFNIX was incepted earlier than LHCFX: JFNIX (16 years) vs LHCFX (6 years). LHCFX (3.19) is less costly to investors than JFNIX (0.77). LHCFX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCFX has a lower initial minimum investment than JFNIX: LHCFX (0) vs JFNIX (2500). LHCFX annual gain was more profitable for investors over the last year : -1.00 vs. JFNIX (-12.88). LHCFX return over 5 years is better than : 11.08 vs. JFNIX (10.19).
JFNIXLHCFXJFNIX / LHCFX
Total Expense Ratio0.770.7899%
Annual Report Gross Expense Ratio0.773.1924%
Fund Existence16 years6 years-
Gain YTD3.8523.763102%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.8M54,964%
Annual Yield % from dividends0.390.4587%
Returns for 1 year-12.88-1.001,292%
Returns for 3 years17.0219.9185%
Returns for 5 years10.1911.0892%
Returns for 10 years22.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJPTX14.960.14
+0.94%
VY® JPMorgan Emerging Markets Equity S2
PGLEX19.150.09
+0.47%
Putnam Focused International Equity R6
FFANX13.970.04
+0.29%
Fidelity Asset Manager 40%
OMGCX27.10N/A
N/A
JPMorgan Mid Cap Growth C
AFAVX14.42N/A
N/A
AMG River Road Focused Absolute Value I